Beruflich Dokumente
Kultur Dokumente
PHCL 2XX
Dr VN NDIKUM
1
Pharmacokinetic Overview .
1 2
Pharmacokinetic Overview .
Definition of PK:
The study of the movement of drugs in the body, including
the processes of absorption, distribution, localization in tissues, biotransformation and excretion. The actions of the body on the drug are called pharmacokinetic processes
Pharmacokinetic processes govern the absorption, distribution, metabolism and elimination of drugs Learning pharmacokinetics is of great practical importance in the choice and administration of a particular drug for a particular patient, e.g., one with impaired cardiac, hepatic or renal function
Drug Absorption
Absorption is the process by which a drug enters the bloodstream without being chemically altered, Or The movement of a drug from its site of application into the blood or lymphatic system.
NB: Absorption is instantaneous for bolus intravenous administration. Drugs taken by mouth pass to the stomach & then the intestine they are absorbed from the GItract into the circulatory system
6
Most drugs cross biomembranes by passive diffusion where the rate of absorption is proportional to the drug concentration gradient. In which case will the rate be larger? A Out In B Out In
7
11
12
Passive diffusion Aqueous diffusion Drug passes through aqueous pores in biomembranes BUT these pores limited to molecular wts of <40 Lipid Diffusion -drug if hydrophopic and uncharged dissolves in lipid (hydrophobic components) of biomembranes
15
2.
Active transport
is a carrier mediated transport system, energy is required and the transport is against a concentration gradient. is characterized by saturability, selectivity, and competitiveness.
3.
Pinocytosis
requires energy. The transport mechanism is by invagination of the cell membrane to form a vesicle and the engulfing of the invagination
16
Mechanism
Direction
Energy required
Carrier
Satura ble
Passive Along gradient diffusion Facilitated Along gradient diffusion Active transport Against gradient
No
No
No
No
Yes
Yes
Yes
Yes
Yes
17
Drug Absorption:
1. types of transport
Molecular size and shape Lipid solubility Partition coefficient - relation to lipid solubility Weak acids - weak bases
19
20
21
22
Phase 1: a nonpolar liquid or organic solvent (representing the membrane); and Phase 2: an aqueous buffer, pH 7.4 (representing the plasma)
Drug Absorption:
The route of administration (ROA) that is chosen may have a profound effect upon the speed and efficiency with which the drug acts
25
Drug Absorption:
1. types of transport 2. the physicochemical properties of the drug 3. routes of administration 4. dosage forms 5. circulation at the site of absorption
6. concentration of the drug
26
The concentration of a drug at the site of absorption could influence the rate of absorption The higher the concentration, the higher the rate of absorption Example:
Time-release preparations
Oral - controlled-release, timed-release, sustained-release designed to produce slow,uniform absorption for 8 hours or longer better compliance, maintain effect over night, eliminate extreme peaks and troughs parental administration (except IV), may be prolonged by
Drug Absorption:
1. types of transport 2. the physicochemical properties of the drug 3. routes of administration 4. dosage forms 5. circulation at the site of absorption 6. concentration of the drug
28
drug could also determine the rate of absorption. The rate of absorption will depend on the solubility and ease of dissolution of the drug
29
Drug Absorption:
1. types of transport 2. the physicochemical properties of the drug 3. routes of administration 4. dosage forms 5. circulation at the site of absorption 6. concentration of the drug
30
Blood circulation at various organs The rate of absorption will also depend on the rate of blood flow in the organ where the drug is absorbed.
31
Skeletal muscle
Skin Placenta and fetal (term) Whole body
34.4
4.0 3.8 70
840
462 500 5400
15.6
8.6 9
32
100
In summary
The Rate of Absorption is determined
by the physical characteristics of the drug, the speed which the drug is absorbed and/ or released, as well as the need to bypass hepatic metabolism and achieve high conc. at particular sites
33
Dose
to systemic circulation
34
35
effect.
Intravenous
37
3. Cmax
38
Bioavailability (F):
Bioavailability (F):
Absolute Bioavailability:
the fraction of the dose that reaches the systemic circulation. (F=1 for IV administration.) Estimation of F for any other route in comparison to intravenous administration.
Estimation of F for a dosage form to another given by an extravascular (non-intravenous) route of administration.
39
Relative Bioavailability:
Determinants of BIOAVAILABIITY
Affected by:
(eg: Lidocaine, propranolol) Solubility Instability (eg: Penicillin G, insulin)
Serum Concentration
Injected Dose
Oral Dose
Time
40
41
42
Bioavailability
The fraction of the dose of a drug (F) that enters the general circulatory system, F= amt. Of drug that enters systemic circul.
Dose administered
F = AUC/Dose
43
Examples:
If the drugs bioavailability is 50%, the body
44
IV Oral Rectal
120 min
180 min
45
IV Oral Rectal
120 min
180 min
46
Cmax = maximal drug level obtained with the dose. Tmax = time at which Cmax occurs. Lag time = time from administration to appearance in blood. Onset of activity = time from administration to blood level reaching minimal effective concentration (MEC). Duration of action = time plasma concentration remains greater than MEC.
47
48